Free Trial

Jaguar Health (JAGX) Competitors

Jaguar Health logo
$9.10 +1.04 (+12.87%)
As of 10:17 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

JAGX vs. LPTX, BIVI, MIRA, GLYC, ABVC, NRSN, COCP, PHIO, INAB, and CLRB

Should you be buying Jaguar Health stock or one of its competitors? The main competitors of Jaguar Health include Leap Therapeutics (LPTX), BioVie (BIVI), MIRA Pharmaceuticals (MIRA), GlycoMimetics (GLYC), ABVC BioPharma (ABVC), NeuroSense Therapeutics (NRSN), Cocrystal Pharma (COCP), Phio Pharmaceuticals (PHIO), IN8bio (INAB), and Cellectar Biosciences (CLRB). These companies are all part of the "pharmaceutical products" industry.

Jaguar Health vs.

Jaguar Health (NASDAQ:JAGX) and Leap Therapeutics (NASDAQ:LPTX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, community ranking, risk, earnings and media sentiment.

12.0% of Jaguar Health shares are owned by institutional investors. Comparatively, 30.5% of Leap Therapeutics shares are owned by institutional investors. 0.4% of Jaguar Health shares are owned by insiders. Comparatively, 5.4% of Leap Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Jaguar Health has higher revenue and earnings than Leap Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jaguar Health$11.69M0.46-$41.30MN/AN/A
Leap TherapeuticsN/AN/A-$81.41M-$1.84-0.21

In the previous week, Jaguar Health's average media sentiment score of 0.00 equaled Leap Therapeutics'average media sentiment score.

Company Overall Sentiment
Jaguar Health Neutral
Leap Therapeutics Neutral

Jaguar Health has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Comparatively, Leap Therapeutics has a beta of 0.22, meaning that its share price is 78% less volatile than the S&P 500.

Leap Therapeutics has a consensus target price of $4.92, suggesting a potential upside of 1,150.74%. Given Leap Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Leap Therapeutics is more favorable than Jaguar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jaguar Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Leap Therapeutics
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25

Jaguar Health received 1541 more outperform votes than Leap Therapeutics when rated by MarketBeat users. Likewise, 88.65% of users gave Jaguar Health an outperform vote while only 68.37% of users gave Leap Therapeutics an outperform vote.

CompanyUnderperformOutperform
Jaguar HealthOutperform Votes
1835
88.65%
Underperform Votes
235
11.35%
Leap TherapeuticsOutperform Votes
294
68.37%
Underperform Votes
136
31.63%

Leap Therapeutics has a net margin of 0.00% compared to Jaguar Health's net margin of -360.13%. Leap Therapeutics' return on equity of -116.24% beat Jaguar Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Jaguar Health-360.13% -326.62% -67.02%
Leap Therapeutics N/A -116.24%-93.18%

Summary

Leap Therapeutics beats Jaguar Health on 7 of the 13 factors compared between the two stocks.

Get Jaguar Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JAGX vs. The Competition

MetricJaguar HealthPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$5.43M$6.59B$5.40B$7.70B
Dividend YieldN/A3.20%5.44%4.32%
P/E RatioN/A7.0522.1918.33
Price / Sales0.46273.45402.50107.05
Price / CashN/A65.6738.2034.62
Price / Book2.006.506.844.25
Net Income-$41.30M$142.50M$3.20B$247.51M
7 Day Performance46.28%8.32%5.93%6.33%
1 Month Performance48.98%-5.61%-4.18%-3.33%
1 Year Performance-96.84%0.11%17.99%5.15%

Jaguar Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JAGX
Jaguar Health
0.024 of 5 stars
$9.10
+12.9%
N/A-96.8%$6.25M$11.69M0.0050
LPTX
Leap Therapeutics
1.3003 of 5 stars
$0.36
-1.0%
$4.92
+1,267.3%
-88.1%$14.84MN/A-0.1940
BIVI
BioVie
1.3155 of 5 stars
$0.79
-5.6%
$3.00
+277.8%
+76.9%$14.65MN/A-0.0810
MIRA
MIRA Pharmaceuticals
2.4592 of 5 stars
$0.87
-7.9%
$14.00
+1,518.5%
+14.3%$14.54MN/A-1.542
GLYC
GlycoMimetics
1.9485 of 5 stars
$0.22
-1.3%
N/A-86.5%$14.19M$10,000.00-0.3750Analyst Forecast
News Coverage
ABVC
ABVC BioPharma
0.6236 of 5 stars
$0.87
+2.1%
N/A-38.4%$13.77M$509,788.00-1.0130
NRSN
NeuroSense Therapeutics
0.2765 of 5 stars
$1.00
-3.2%
N/A-25.4%$13.67MN/A-1.5610News Coverage
Gap Up
COCP
Cocrystal Pharma
1.9393 of 5 stars
$1.34
+1.9%
$7.00
+424.2%
-2.7%$13.58MN/A-0.7210News Coverage
Gap Up
PHIO
Phio Pharmaceuticals
2.6979 of 5 stars
$2.83
+3.7%
$4.00
+41.3%
-63.1%$13.52MN/A-0.2610Positive News
INAB
IN8bio
3.0708 of 5 stars
$0.17
+3.3%
$6.00
+3,510.1%
-82.5%$13.51MN/A-0.2220Positive News
CLRB
Cellectar Biosciences
2.2016 of 5 stars
$0.29
-2.9%
$12.50
+4,207.4%
-89.8%$13.37MN/A-0.1710

Related Companies and Tools


This page (NASDAQ:JAGX) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners